“What we are trying to do more often is to ablate as much as we can,” said Shankar Siva, MBBS, PhD, FRANZCR, on pairing SABR with systemic therapy in RCC.
|Videos|June 28, 2017
Could SBRT Have Role in Metastatic Kidney Cancer?
Author(s)Thomas Schwaab, MD, PhD
This video examines a pilot trial that tested stereotactic body radiotherapy plus nephrectomy in patients with renal cell carcinoma.
Advertisement
In this video, Thomas Schwaab, MD, PhD, of Roswell Park Cancer Institute in Buffalo, New York, discusses a pilot trial that tested stereotactic body radiotherapy (SBRT) plus nephrectomy in patients with renal cell carcinoma.
The
Video courtesy of
Advertisement
Related to this article
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves SC Amivantamab for Recurrent/Metastatic HNSCC
2
FDA Sets PDUFA Date for Rivoceranib/Camrelizumab Resubmission After Third CRL in Unresectable HCC
3
Sacituzumab Govitecan Efficacy, Safety Debated in First-Line Metastatic TNBC
4
Air Pollution Emerges as Second Leading Risk Factor for Lung Cancer Deaths
5